Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Pulsed corticosteroid treatment in MS patients stabilizes disease activity following natalizumab withdrawal prior to switching to fingolimod.
Natalizumab treatment in multiple sclerosis: the experience from two Brazilian MS centers.
Chronic inflammatory demyelinating polyradiculoneuropathy with cholesterol deposits in a dog.
[Animal models for multiple sclerosis].
Relapsing Remitting Multiple Sclerosis in an Iranian Patient with Neurofibromatosis Type I.
Protective effect of naringin on 3-nitropropionic acid-induced neurodegeneration through the modulation of matrix metalloproteinases and glial fibrillary acidic protein.
Reliability and validity of the function in sitting test in nonambulatory individuals with multiple sclerosis.
Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis.
Inhibition of 12/15-lipoxygenase by baicalein induces microglia PPARβ/δ: a potential therapeutic role for CNS autoimmune disease.
False positivity of anti aquaporin-4 antibodies in natalizumab-treated patients.
Researchers Expand Focus on Progressive Forms Of Multiple Sclerosis: Efforts to Pinpoint the Beginning of Disease May Yield Clues to Treatment.
Monthly oral methylprednisolone pulse treatment in progressive multiple sclerosis.
No evidence for a role of Ile587Val polymorphism of EIF2B5 gene in multiple sclerosis in Kashmir Valley of India.
Reply to the Comment by Yolcu et al. on Our Paper Entitled ´Evaluation of Choroidal Vascular Changes in Patients with Multiple Sclerosis Using Enhanced Depth Imaging Optical Coherence Tomography´.
Does the changing sex ratio of multiple sclerosis give opportunities for intervention?
[Argyrophil fibrils in the foci of multiple sclerosis; tissue in the central nervous parenchyma].
A novel internet-based method of capturing outcomes in multiple sclerosis.
Metabolite Changes in Normal Appearing Cervical Spinal Cord in Two Patients with Multiple Sclerosis. A Proton MR Spectroscopic Analysis.
Astrocyte-specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor.
Direct visualization of short transverse relaxation time component (ViSTa).
In vitro-induced cell-mediated immune deviation to encephalitogenic antigens.
The role of myelin and oligodendrocytes in axonal energy metabolism.
Incidence of human herpesvirus 6 in clinical samples from Swedish patients with demyelinating diseases.
Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease.
Risk factors of early onset of MS in women in reproductive age period: survival analysis approach.
Pages
« first
‹ previous
…
703
704
705
706
707
708
709
710
711
…
next ›
last »